Answers are grounded in this paper and cite their sources.
The purpose of this workshop was to derive a consensus statement regarding the diagnosis and treatment of lymphedema following breast carcinoma therapy. There was consensus on the importance of the patient's subjective presentation with early changes; the importance of early management of patients during the first months after breast carcinoma therapy; and the importance of a multidisciplinary approach to the therapy of lymphedema, with differentiation among those modalities that achieve volume reduction of the involved limb from those that maintain long term beneficial therapeutic effects.
No takes yet. Share an insight, caveat, or question.
Rockson et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: